Login / Signup

The Optimal Combination of Dietary Starch, Non-Starch Polysaccharides, and Mannan-Oligosaccharide Increases the Growth Performance and Improves Butyrate-Producing Bacteria of Weaned Pigs.

Hua ZhouBing YuJun HeXiangbing MaoPing ZhengJie YuJunqiu LuoYuheng LuoHui YanDaiwen Chen
Published in: Animals : an open access journal from MDPI (2020)
The present experiment was conducted to dissect the effects of different carbohydrate combinations on the growth performance, nutrient digestibility, and microbial communities in weaned pigs. The combination was optimized by constructing L9(34) orthogonal design. Three factors include starch (amylose to amylopectin (AM/AP) ratio 2:1, 1:1, 1:2), non-starch polysaccharides (NSP) (1%, 2%, 3%, a mixture of inulin with cellulose by 1:1), and mannan-oligosaccharide (MOS) (400, 800, 1200 mg/kg) were investigated and nine combinations were implemented under different levels of these factors. One hundred and sixty-two weaned pigs were randomly assigned to nine dietary treatments with six replicates per treatment and three pigs per replicate. Results exhibited that different combinations of starch, NSP, and MOS affected the gain to feed (G:F) (p < 0.05), diarrhea incidence (p < 0.10), nutrient digestibility (p < 0.05), microbial communities, and short-chain fatty acid (SCFA) concentrations (p < 0.05). In the present study, taking into account three-way ANOVA, range, and direct analysis, we found that the optimal carbohydrate combination was starch AM/AP 1:1, NSP 3%, MOS 400 mg/kg for weaned pigs. Moreover, feeding this combination diet could promote the growth performance and nutrient digestibility, increase the butyrate-producing bacteria, and to some extent improve lipid metabolism. This study provided a novel way to evaluate the carbohydrate quality in swine production.
Keyphrases
  • fatty acid
  • quantum dots
  • lactic acid
  • room temperature
  • transcription factor
  • physical activity
  • risk factors
  • mass spectrometry
  • ionic liquid
  • visible light
  • transition metal
  • combination therapy
  • silver nanoparticles